Massive Bio and Un Ensayo Para Mi Team up to Transform Oncology Clinical Trial

Massive Bio, an international leader in AI-driven oncology solutions, and Un Ensayo Para Mi (UEPM), Latin America's foremost clinical trial search portal, are pleased to announce an expanded collaboration. This agreement will expand Massive Bio's reach to nine Latin American nations, including Mexico, Colombia, Brazil, and Argentina, in order to improve clinical trial access and patient care.

Dr. Selin Kurnaz, PhD, Co-Founder and CEO of Massive Bio, remarked, "Expanding our collaboration with UEPM is a pivotal step in our mission to democratize access to clinical trials globally. By leveraging UEPM’s extensive network and our AI technology, we can ensure that more patients in LATAM have access to cutting-edge therapies."

Massive Bio's breakthrough AI technology improves the clinical trial enrollment process, saving time and effort on patient matching. This collaboration will improve access to clinical trials for cancer patients in LATAM, bridging the gap between innovative therapies and those who need them the most.

Dr. Georgina Sposetti, CEO and Founder of Un Ensayo Para Mi, stated, "We are thrilled to partner with Massive Bio to bring advanced oncology clinical trial matching to our region. This collaboration will significantly improve the accessibility and efficiency of finding suitable clinical trials for our cancer patients, ultimately enhancing their treatment outcomes and quality of life."